US biotech company Moderna has halted the construction of a $500 million mRNA vaccine plant in Kenya due to a drop in COVID-19 vaccine demand.  Moderna said it has not received any vaccine orders for Africa since 2022. It has taken over $1 billion in losses and write-downs related to…